Director, New Products Value and Evidence

Role: Lead the U.S. market access scientific strategy and evidence generation for pipeline products in Johnson & Johnson's Innovative Medicine division. Objectives include integrating real-world evidence early in development, supporting differentiated value propositions, and addressing evolving payer and policy requirements, such as the Inflation Reduction Act, to ensure patient access and regulatory compliance. Responsibilities encompass designing and executing research to inform development and launch strategies, managing evidence dissemination, and collaborating with cross-functional teams on scientific and market access initiatives. The role also involves analyzing policy impacts, overseeing external research and publications, and serving as a subject-matter expert on health technology assessments. Qualifications: Master's degree in relevant health sciences; 7+ years of research and health economics experience, with expertise in real-world evidence, health policy, and U.S. healthcare payer landscape. Skills include leadership, strategic planning, data analysis, and effective communication of complex scientific data to diverse audiences. Preferred: Development of value-based scientific strategies aligned with commercial goals. High-Value: Focus on health economics, outcomes research, real-world data analytics, U.S. healthcare system, payer and policy engagement, and evidence communication. Location: Titusville, NJ, with up to 30% domestic travel.